CHEMICAL

PROCESSING
SOLUTIONS
→ THE WORLD PRODUCES
2.8 MILLION TONS OF
HIGHLY CORROSIVE HCl EACH YEAR

To foster the progression and safety of the CPI

market there is a need for extreme chemical
resistance and long-standing performance
paired with high temperature performance.

Titre de la présentation 2
1
Titre de la présentation
Overview

3
CPI applications and relevant chemicals

Metal
Pulp & Paper Petrochemicals Food & Beverage Waste Water
Preparation

Chemical
High Alkylation acids, FDA listing,
Bleaching mixtures,
temperature hydrocarbon steam cleaning,
chemicals outdoor
acids mixtures acidic foods
exposure

General Pharmaceutical/
Mining Semi-Conductor Plenum Pipe
Chemicals Biotech

High purity Ozone, steam

High abrasion & Acid waste
pH <1 to13.5 water, acids, cleanable, FDA
chemicals drainage
ozone acids

Titre de la présentation 4
Chemical processing ≠ easy

EXTREME à Temperatures Regulations Corrosion

Chemicals

Hydrochloric H

Cl
acid

H
O
Sulfuric
O S O
acid O
H

-
B
Bromide r

Maintenance is costly
à both time and money

Titre de la présentation 5
 Performance starts at processing

Yellowness after molding of PVDF plates at 230ºC

23

18
Yellowness Index (YI)

13
Competition

PVDF 1 PVDF 2 PVDF 3 PVDF 4 PVDF 5 PVDF 6 PVDF 7 PVDF 8 Kynar®

-2
PVDF
Comparative PVDF grades
10 minutes 30 minutes

Titre de la présentation 6
 Retention of whiteness

Whiteness of plaque before/after 990h at 130ºC

45
t=0 t = 990h
40
35
Yellowness Index (YI)

30
25
20
15
10
5
0
PVDF 1 PVDF 2 PVDF 3 PVDF 4 PVDF 5 PVDF 6 PVDF 7 PVDF 8 Kynar®
-5 PVDF
Comparative PVDF grades

Before After

Titre de la présentation 7
Chemical exposure – whiteness retention

Extrusion of thick plates

7 days in 96% H2SO4 at 50ºC

7 days in 37% HCl at 50ºC

Titre de la présentation 8
Many fluoropolymers – one standout

PVF PVDF PCTFE PTFE

F H F F F F
Homopolymers C C C
C C C
H H Cl F F F

FEP PFA ETFE E-CTFE

F F F F F F F F
F F C F F C H H C H H C
Copolymers C C C C C C C C
C F C F C F C Cl
F F F F
F C F O H H H H
F F F F
F
C F
F C
C F
F F

Titre de la présentation 9
Many fluoropolymers – one standout

PVDF has the best balance of mechanical properties

and melt processability among all the
fluoropolymers

PVDF PTFE PFA FEP ETFE ECTFE PCTFE

Density 1.79 2.18 2.15 2.14 1.76 1.68 2.13

Tensile yield strength
(MPa)
48 14 19 15 28 31 40
Flexural modulus
(MPa)
2000 550 600 620 1100 1700 1500

Dielectric constant 8 1.9 1.9 1.9 2.2 2.5 2.6

LOI % 44 90 90 90 30 60 90
Decomposition (°C) 340 400 400 ~300 360 ~320 320
Tm (°C) 170 342 305-307 275-295 270 240-247 214

Titre de la présentation 10
 Chemical exposure – whiteness retention

7 days 50ºC

Control 69.8% HNO3 96% H2SO4 37% HCl

11

Titre de la présentation 11
Kynar® in CPI applications : chemical resistance 93°C

halogenated solvents
5
4,5
strong oxidants 4 esters, ketones
3,5 PVDF PVC HDPE PP PES-GF
3
2,5
2 5 : Excellent resistance
1,5 4 : Fair resistance
3 : Limited resistance
halogens 1 aromatic solvents
2 : Low resistance
0,5
1 : No resistance
0

strong acids aliphatic solvents

strong bases weak bases

Titre de la présentation 12
Reduced bacteria & microrganisme build-up

Smooth surface texture

prevents build-up of bacteria

50µm 50µm

Titre de la présentation 13
CPI – by the application

Tower Packing,
Stock Shapes (rods, sheets) Tubing, Molding, Plenum Pipe Filters,
Compounds

Kynar® 1000HD Kynar® 1000HD Kynar® 9000HD

Kynar® 740 Kynar® 9000HD Kynar® 720

Kynar® 740

Kynar® 720

For lower viscosity: 4000 series and 6000 series EXTREME WHITENESS AND PERFORMANCE

Kynar® UHM glass filled grades available EXCELLENT PERFORMANCE BALANCE

Titre de la présentation 14
Kynar® PVDF vs. suspension PVDF

Property Kynar® PVDF Suspension PVDF

Melting Point 167-172ºC 170-180ºC

HDT (0.45MPa) 145ºC 156ºC

Rockwell 110-115 115

Mechanical Properties Equivalent

Electrical Properties Equivalent

Heat Stability High Decomposition at lower T

Melt Processability Good Surface roughness

Purity High Purity Slightly lower

Chemical Resistance Good Good but color change

Titre de la présentation 15
Kynar® ADX for powder coatings

Allows primer less powder coating (direct adhesion to metals)

after standard surface preparation
Can be used easily in the standard application processes:
Dip coating in fluidized bed
Electrostatic spraying
Hot spraying

Product range:
Kynar® ADX 281 :
PVDF copolymer
Natural version ð aspect, easy identification/differentiation
Image courtesy of SALCO PRODUCTS
Strong experience of Kynar® PVDF in CPI applications
Similar chemical resistance as regular Kynar® PVDF
Durable adhesion ensured by thickness enough and low Melt Point (°C) Flex Modulus at Characteristics
permeation of fluids in contact 23°C (Mpa)
156 1000 Thermal cycling
flexibility

Titre de la présentation 16
 © Copyright 2021 Arkema – All rights reserved. Do not copy without express
permission from Arkema.

Rilsan®, Pebax®, Rnew®, Virtucycle®, Kynar®, Kynar 500®, Kynar

Aquatec®, Kepstan®, Orgasol®, FSF® are registered trademarks of Arkema.

Arkema strictly prohibits the use of any polymers, including medical grades, in applications that are
implanted in the body or in contact with bodily fluids or tissues for greater than 30 days. Unless Arkema
otherwise expressly agrees by written contract, the Arkema trademarks and the Arkema name shall not be
used in conjunction with customers’ medical devices, including without limitation, permanent or temporary
implantable devices, and customers shall not represent to anyone else, that Arkema allows, endorses or
permits the use of Arkema products in such medical devices. Further, all implantable medical devices,
whether permanent or temporary, carry a risk of adverse consequences. With regard to implantable medical
devices, you should not rely upon the judgment of Arkema. Any decision regarding the appropriateness of a
particular medical device in a particular medical application or for a specific clinical use should be based
upon the judgment of your physician, medical device supplier and the United States Food & Drug
Administration and/or the European process of Medical Device notification. Unless otherwise specifically
stated by Arkema in writing, Arkema does not perform clinical medical studies on implantable medical
devices. Arkema cannot weigh the benefits against the risks of a device and does not offer a medical
judgment on the safety or efficacy of use of any Arkema product in a medical device. The statements,
technical information and recommendations contained herein are believed to be accurate as of the date
hereof. Since the conditions and methods of use of the product and of the information referred to herein
are beyond our control, ARKEMA expressly disclaims any and all liability as to any results obtained or arising
from any use of the product or reliance on such information; NO WARRANTY OF FITNESS FOR ANY
PARTICULAR PURPOSE, WARRANTY OF MERCHANTABILITY OR ANY OTHER WARRANTY, EXPRESSED OR
IMPLIED, IS MADE CONCERNING THE GOODS DESCRIBED OR THE INFORMATION PROVIDED HEREIN. The
information provided herein relates only to the specific product designated and may not be applicable when
arkema.com such product is used in combination with other materials or in any process. The user should thoroughly test
any application before commercialization. Nothing contained herein constitutes a license to practice under
any patent and it should not be construed as an inducement to infringe any patent and the user is advised
to take appropriate steps to be sure that any proposed use of the product will not result in patent
infringement.